(Q46803794)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Acute renal failure secondary to imatinib mesylate treatment in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

John R Foringer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Regina R Verani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vincent M Tjia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kevin W Finkel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jayarama S Guntupalli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

15 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2136-2138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16288076%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

9 January 2020

cites work

1 reference

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate

21 January 2018

1 reference

Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571.

21 January 2018

1 reference

Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference